Earl Stoddard, MD
MOHS-Micrographic Surgery · Chubbuck, IDNPI 1760400238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 35.0% of the total. Reporting peaked in 2019 at $796 and has fallen 70.1% since, to $238 in 2025.
Across 153 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Merz North America, Inc.$426
- Johnson & Johnson$279
- Galderma Laboratories, L.p.$191
- Novartis$180
- Regeneron Healthcare Solutions, Inc.$170
- plus $795 from 18 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Speaking & faculty fees$1505%
- Food & beverage$2,89992%
- Education$923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,099 |
| Merz North America, Inc. | 6 | $426 |
| Johnson & Johnson | 14 | $279 |
| Galderma Laboratories, L.p. | 5 | $191 |
| Novartis | 10 | $180 |
| Regeneron Healthcare Solutions, Inc. | 7 | $170 |
| UCB, Inc. | 7 | $125 |
| LEO Pharma Inc. | 6 | $119 |
| Lilly USA, LLC | 7 | $106 |
| Biofrontera Inc. | 4 | $77 |
| Sun Pharmaceutical Industries Inc. | 3 | $55 |
| VYNE Pharmaceuticals Inc. | 1 | $54 |
| Sanofi | 3 | $50 |
| Pfizer | 2 | $29 |
| Prugen, Inc. Pharmaceuticals | 1 | $26 |
| Sandoz | 1 | $25 |
| Boehringer Ingelheim | 1 | $22 |
| Organogenesis Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acitretin | 23 | $10,443 |
| Fluorouracil | 51 | $5,887 |
| Imiquimod | 67 | $2,796 |
| Doxycycline Monohydrate | 26 | $408 |
| Ketoconazole | 20 | $232 |
| Clobetasol Propionate | 11 | $209 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $99 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Chubbuck
- Brandon MinerIdaho Falls$5K
- Daniel WinchesterMeridian$4K
- Ryan ThorpeMeridian$4K
- Daniel MarshallRexburg$2K
- Peter BoothmanMeridian$2K
- David GriffinTwin Falls$789
- Teri CottinghamBoise$149
- Kurtis ReedTwin Falls$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.